Latest stories on ZLDPF
Zealand Pharma: A Play On Medicine Discovery, But Too Expensive Right Now
Seeking Alpha42 · neutralanalyst
Zealand Pharma downgraded to Equal Weight from Overweight at Barclays
The Fly38 · neutralanalyst
Barclays cuts Zealand Pharma stock rating on distant catalysts
Investing.com Analyst Ratings34 · bearishanalyst
Zealand Pharma price target lowered to DKK 435 from DKK 460 at JPMorgan
The Fly38 · neutralanalyst
Zealand Pharma enters $100M royalty purchase, sale pact with Royalty Pharma
The Fly55 · neutralm&a
Zealand Pharma price target raised to DKK 420 from DKK 410 at Wells Fargo
The Fly63 · neutralanalyst
Zealand Pharma GAAP EPS of DKK55.34, revenue of DKK4.49B
Seeking Alpha50 · neutralearnings
Zealand Pharma A/S 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Zealand Pharma Announces Financial Results for the First Half of 2026
Business Insider50 · neutralearnings
Zealand Pharma Announces Financial Results for the First Half of 2026
GlobeNewswire56 · neutralearnings
Zealand gains $100M in funding from Royalty Pharma
Seeking Alpha63 · neutralgeneral
Royalty Pharma, Zealand Pharma Enter Rusfertide Funding Agreement
MarketWatch55 · neutralgeneral
Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million
Business Insider59 · neutralgeneral
Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million
GlobeNewswire59 · neutralm&a
Zealand Pharma’s New Psoriasis Trial Sets Early Stage for ZP9830
TipRanks56 · neutralproduct/pr
Zealand Pharma shares drop 25% after a quarter of patients quit obesity drug trial
Reuters34 · bearishearnings
Zealand Pharma tumbles 24% as weight-loss drug data sparks safety fears
Seeking Alpha28 · bearishearnings
Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial
MarketWatch38 · neutralgeneral
Zealand phase 2 data on petrelintide shows durable weight loss
Seeking Alpha67 · bullishproduct/pr